secwatch / observer

Earnings Releases

Quarterly and annual results disclosed under 8-K Item 2.02.

8-K items 2.02 JSON
EYE National Vision Holdings, Inc.

National Vision Holdings, Inc. reported the fiscal year ended January 3, 2026 results: revenue $1,987.5 million, net income $29.6 million, EPS $0.37. Guidance initiated.

“Fiscal 2025 highlights compared to fiscal year 2024 * : • Net revenue from continuing operations of $1,987.5 million, an increase of 9.0% • Comparable store sales growth of 5.9% and Adjusted Comparable Store Sales Growth of 6.0% • Net income from continuing operations of $29.6 million and Diluted EPS from continuing operations of $0.37, with Income (loss) from continuing operations margin improving to 1.5% from (1.5)% • Adjusted Operating Income from continuing operations of $102.5 million compared with $65.5 million in fiscal year 2024, with Adjusted Operating Margin improving to 5.2% from 3.6% • Adjusted Diluted EPS from continuing operations increased to $0.80 compared with $0.52 in fiscal year 2024”
EYE National Vision Holdings, Inc.

National Vision Holdings, Inc. reported the fourth quarter ended January 3, 2026 results: revenue $503.4 million, net income $3.3 million, EPS $0.04. Guidance initiated.

“Fourth quarter 2025 highlights compared to fourth quarter 2024*: • Net revenue from continuing operations of $503.4 million, increased 15.1% • Comparable store sales growth of 6.6% and Adjusted Comparable Store Sales Growth of 4.8%, represented 12 consecutive quarters of positive growth • Net income from continuing operations of $3.3 million, Diluted EPS from continuing operations of $0.04, with Income (loss) from continuing operations margin improving to 0.7% from (6.7)% • Adjusted Operating Income from continuing operations increased to $17.6 million from $3.2 million, with Adjusted Operating Margin improving to 3.5% from 0.7% • Adjusted Diluted EPS from continuing operations of $0.15 compared with $(0.04)”
VMD VIEMED HEALTHCARE, INC.

VIEMED HEALTHCARE, INC. reported the three months and year ended December 31, 2025 results: revenue $76.2 million, net income $5.6 million, or $0.14 per diluted share, EPS $0.14 per diluted share. Guidance initiated.

“December 31, 2026. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): • Net revenues for the quarter ended December 31, 2025 were a company record $76.2 million, an increase of $15.5 million, or 26%, over net revenues reported for the comparable quarter ended December 31, 2024. Total net revenues for the year ended December 31, 2025 were”
AVGO Broadcom Inc.

Broadcom Inc. reported first quarter ended February 1, 2026 results: revenue $19,311 million, net income GAAP net income of $7,349 million, EPS GAAP diluted EPS of $1.50. Guidance raised.

“Broadcom Inc. Announces First Quarter Fiscal Year 2026 Financial Results and Quarterly Dividend • Revenue of $19,311 million for the first quarter, up 29 percent from the prior year period • GAAP net income of $7,349 million for the first quarter; Non-GAAP net income of $10,185 million for the first quarter • Adjusted EBITDA of $13,128 million for the first quarter, or 68 percent of revenue • GAAP diluted EPS of $1.50 for the first quarter; Non-GAAP diluted EPS of $2.05 for the first quarter • Cash from operations of $8,260 million for the first quarter, less capital expenditures of $250 million, resulted in $8,010 million of free cash flow, or 41 percent of revenue • Quarterly common stock dividend of $0.65 per share • Second quarter fiscal year 2026 revenue guidance of approximately $22.0 billion, an increase of 47 percent from the prior year period • Second quarter fiscal year 2026 Adjusted EBITDA guidance of approximately 68 percent of projected revenue”
ARDT Ardent Health, Inc.

Ardent Health, Inc. reported the quarter ended December 31, 2025 results: revenue $1,605 million, net income $45 million, EPS $0.32 per diluted share. Guidance initiated.

“See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue 4Q25 : $1.61 billion 2025 : $6.32 billion ; 6.0% growth Y/Y Net Income Attributable to Ardent Health 4Q25 : $45 million Adjusted EBITDA (1) 4Q25 : $134 million 2025 : $545 million ; 9.3% growth Y/Y”
STEM STEM, INC.

STEM, INC. reported the twelve months ended December 31, 2025 results: revenue $156.3 million, net income Net income of $137.8 million. Guidance initiated.

“• Revenue of $156.3 million, up 8% from $144.6 million for FY24 • Software, services, and edge hardware revenue of $141.4 million, up 25% from $113.2 million for FY24 • GAAP gross profit of $60.0 million, up from $(11.1) million for FY24 • Non-GAAP gross profit of $72.3 million, up from $63.7 million for FY24 • GAAP gross margin of 38%, versus (8)% for FY24 • Non-GAAP gross margin of 46%, versus 35% for FY24 • Net income of $137.8 million versus net loss of $854.0 million for FY24 • Adjusted EBITDA of $6.7 million versus $(22.8) million for FY24 • Operating cash flow of $6.9 million versus $(36.7) million for FY24”
STEM STEM, INC.

STEM, INC. reported the three months ended December 31, 2025 results: revenue $47.2 million, net income Net loss of $16.0 million. Guidance initiated.

“• Revenue of $47.2 million, down 15% from $55.8 million in 4Q24 • Software, services, and edge hardware revenue of $46.5 million, up 62% from $28.8 million in 4Q24 • GAAP gross profit of $23.2 million, up from $(2.5) million in 4Q24 • Non-GAAP gross profit of $20.9 million, up from $20.2 million in 4Q24 • GAAP gross margin of 49%, up from (4)% in 4Q24 • Non-GAAP gross margin of 45%, up from 36% in 4Q24 • Net loss of $16.0 million versus net loss of $51.1 million in 4Q24 • Adjusted EBITDA of $5.5 million versus $4.2 million in 4Q24 • Operating cash flow of $8.2 million versus $(14.7) million in 4Q24 • Ended 4Q25 with $48.9 million in cash and cash equivalents versus $43.1 million in 3Q25”
GO Grocery Outlet Holding Corp.

Grocery Outlet Holding Corp. reported the fiscal quarter and fiscal year ended January 3, 2026 results: revenue $1.22 billion, net income Net loss was $218.2 million, EPS $(2.22) per diluted share.

“long-term profitability and increase cash flow generation. Highlights for Fourth Quarter Fiscal 2025 as compared to Fourth Quarter Fiscal 2024: • Net sales increased by 10.7% to $1.22 billion, which includes $82.4 million from the 53rd week. • Comparable store sales declined by 0.8% on a 13-week basis. • Gross margin was 29.7% compared to 29.5% last year. • Operating”
CHPT ChargePoint Holdings, Inc.

ChargePoint Holdings, Inc. reported financial results for its fiscal fourth quarter and full year ended January 31, 2026.

“On March 4, 2026, ChargePoint Holdings, Inc. (the “Company”) issued a press release announcing its financial results for its fiscal fourth quarter and full year ended January 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.”
TCRX TScan Therapeutics, Inc.

TScan Therapeutics, Inc. reported for the fourth quarter and fiscal year ended December 31, 2025 results: revenue $2.6 million.

“sharing preclinical proof-of-concept data for its therapeutic approach in the second half of 2026. Financial Results Revenue: Revenue for the fourth quarter of 2025 was $2.6 million, compared to $0.7 million for the fourth quarter of 2024, and $10.3 million for the full-year 2025, compared to $2.8 million for the full-year 2024. The increase in both periods”
SES SES AI Corp

SES AI Corp reported the fiscal year ended December 31, 2025 results: revenue $21 million.

“Full year revenue reached $21 million, up from just over $2 million in 2024 — nearly 10-fold growth in the first full year we had any revenue at all.”
AFCG Advanced Flower Capital Inc.

Advanced Flower Capital Inc. reported the full year 2025 results: net income $(20.7) million, EPS $(0.95) per basic weighted average common share.

“The Company reported GAAP net loss of $(20.7) million, or $(0.95) per basic weighted average common share, and Distributable Earnings of $8.7 million, or $0.39 per basic weighted average common share, for the full year 2025.”
AFCG Advanced Flower Capital Inc.

Advanced Flower Capital Inc. reported the fourth quarter of 2025 results: net income $0.9 million, EPS $0.04 per basic weighted average common share.

“AFC reported generally accepted accounting principles (“GAAP”) net income of $0.9 million, or $0.04 per basic weighted average common share, and Distributable Earnings of $(2.8) million, or $(0.12) per basic weighted average common share, for the fourth quarter of 2025.”
HLLY Holley Inc.

Holley Inc. reported fourth quarter and full year ended December 31, 2025 results: revenue $155.4 million, net income $6.3 million, EPS $0.05 per diluted share.

“today announced financial results for its fourth quarter and full year ended December 31, 2025. Fourth Quarter Highlights vs. Prior Year Period • Net Sales increased 10.9% to $155.4 million compared to $140.1 million last year • Core business net sales 1 for the fourth quarter of 2025 grew by 13.5% compared to the fourth quarter of 2024 after excluding non-core”
PEPG PepGen Inc.

PepGen Inc. reported financial results for the quarter and year-ended December 31, 2025.

“PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the quarter and year-ended December 31, 2025, and recent corporate highlights.”
SMRT SmartRent, Inc.

SmartRent, Inc. reported the fiscal year ended December 31, 2025 results: revenue $152.3 million, net income Net loss increased to $60.6 million.

“Full Year 2025 Highlights; • Total Revenue of $152.3 million, down 13% from prior year, primarily due to 2024 bulk hardware sales with no current year counterpart. • Reduced total operating expenses by approximately $13.2 million, partially offset by the impact of lower hardware revenues. • Net loss increased to $60.6 million, which included the impact of a goodwill impairment charge of $24.9 million, compared with $33.6 million in the prior year.”
SMRT SmartRent, Inc.

SmartRent, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $36.5 million, net income Net loss aggregated $3.2 million.

“SmartRent Reports Fourth Quarter and Full Year 2025 Financial Results Company Delivers Fourth Quarter 2025 Year-Over-Year Revenue Growth, Positive Adjusted EBITDA, and Maintains Strong Liquidity Phoenix, Ariz., March 4, 2026 – (BUSINESS WIRE) – SmartRent, Inc. (NYSE: SMRT) (“SmartRent” or the “Company”), a leading provider of smart communities and operations solutions for the rental housing industry, today reported financial results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Highlights; • Total Revenue of $36.5 million, up 3% from prior year. • Annual Recurring Revenue ("ARR") increased by 13% year over year to $61.6 million, now representing 42% of total revenue. • Net loss aggregated $3.2 million compared with $11.4 million in the same quarter prior year.”
RGTI Rigetti Computing, Inc.

Rigetti Computing, Inc. reported the year ended December 31, 2025 results: revenue $7.1 million, net income $216.2 million, EPS $(0.70).

“For the year ended December 31, 2025: Total revenues $7.1 million; GAAP net loss $216.2 million; non-GAAP net loss $50.5 million; GAAP net loss per share $(0.70); non-GAAP net loss per share $(0.16)”
RGTI Rigetti Computing, Inc.

Rigetti Computing, Inc. reported the three months ended December 31, 2025 results: revenue $1.9 million, net income $18.2 million, EPS $(0.06).

“Total revenues for the three months ended December 31, 2025 were $1.9 million ● Operating loss for the three months ended December 31, 2025 was $22.6 million ● For the three months ended December 31, 2025: GAAP net loss $18.2 million; non-GAAP net loss $11.3 million ● For the three months ended December 31, 2025: GAAP net loss per share $(0.06); non-GAAP net loss per share $(0.03)”
OABI OmniAb, Inc.

OmniAb, Inc. updated its fiscal year 2026 guidance (initiated).

“OmniAb expects 2026 revenue to be in the range of $25 million to $30 million, and costs and operating expenses to be in the range of $80 million to $85 million.”
OABI OmniAb, Inc.

OmniAb, Inc. reported the year ended December 31, 2025 results: revenue $18.7 million, net income $64.8 million, EPS $0.57 per share.

“Revenue for 2025 was $18.7 million, compared with $26.4 million for 2024. The decline was primarily due to a decrease in license revenue of $2.5 million and milestone revenue of $1.6 million. Service revenue declined as a result of the completion or discontinuation of certain legacy small molecule ion channel programs. These decreases were offset by the addition of $0.8 million in xPloration revenue reflecting the sale of an instrument and related consumables. Cost of xPloration revenue was $0.3 million for 2025 and consisted of direct costs associated with the sale of the xPloration instrument and associated consumables. Research and development expense was $47.8 million for 2025 , compared with $55.1 million for 2024, primarily due to lower personnel expenses related to reduced headcount and share-based compensation expense, lower external expenses associated with legacy small molecule ion channel programs and a decline in contract research costs, partially offset by a $3.9 million i”
OABI OmniAb, Inc.

OmniAb, Inc. reported the fourth quarter of 2025 results: revenue $8.4 million, net income $14.2 million, EPS $0.11 per share.

“Revenue for the fourth quarter of 2025 was $8.4 million, compared with $10.8 million for the same period in 2024, with the decrease primarily related to a decline in license revenue and service revenue, partially offset by an increase in milestone and royalty revenue and the addition of xPloration revenue . Research and development expense was $13.9 million for the fourth quarter of 2025, compared with $13.3 million for the same period in 2024, with the increase due to a $3.9 million impairment charge primarily related to certain small molecule ion channel property and equipment, partially offset by lower personnel expenses related to reduced headcount and share-based compensation expense, and lower external expenses associated with legacy small molecule ion channel programs. General and administrative expense was $6.8 million for the fourth quarter of 2025, compared with $7.4 million for the same period in 2024, with the decrease primarily due to lower share-based compensation expense”
BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd. reported full year 2026 results: revenue $495 - $510 MM. Guidance raised.

“Full Year 2026 Guidance Bowman raised net revenue guidance for full year 2026: Date Issued Net Revenue Adjusted EBITDA Margin November 2025 $465 - $480 MM 17.0% - 17.5% March 2026 $495 - $510 MM 17.0% - 17.5%”
BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd. reported the full year ended December 31, 2025 results: revenue Gross contract revenue of $490.0 million, net income Net income of $12.8 million, EPS Basic and Diluted EPS of $0.74 and $0.73 respectively.

“Full-Year 2025 Compared to Full-Year 2024 Financial Results: • Gross contract revenue of $490.0 million compared to $426.6 million, a 14.9% increase • Net service billing 1 of $434.8 million compared to $379.7 million, a 14.5% increase • Organic net service billing 2 growth of 12.4% compared to 13.1% • Net income of $12.8 million compared to $3.0 million • Basic and Diluted EPS of $0.74 and $0.73 respectively compared to $0.18 and $0.17 respectively”
BWMN Bowman Consulting Group Ltd.

Bowman Consulting Group Ltd. reported the fourth quarter ended December 31, 2025 results: revenue Gross contract revenue of $129.0 million, net income Net income of $2.0 million, EPS Basic and Diluted EPS of $0.11.

“Fourth Quarter 2025 Compared to Fourth Quarter 2024 Financial Results: • Gross contract revenue of $129.0 million compared to $113.2 million, a 14.0% increase • Net service billing 1 of $114.6 million compared to $98.6 million, a 16.2% increase • Organic net service billing 2 growth of 10.9% compared to 8.5% • Net income of $2.0 million compared to $5.9 million 4 • Basic and Diluted EPS of $0.11 compared to $0.34 and $0.33 respectively”
EWCZ European Wax Center, Inc.

European Wax Center, Inc. reported Fiscal 2025 results: revenue $206.6 million, net income Net income of $11.9 million.

“Annual Results for Fiscal 2025 versus Fiscal 2024 • Franchisees opened 11 and closed 31 centers in fiscal 2025. • System-wide sales of $947.3 million decreased 0.4% from $951.0 million compared to the prior year. • Total revenue of $206.6 million decreased 4.7% from $216.9 million in the prior year. • Same-store sales increased 0.2%. • Selling, general and administrative expenses (“SG&A”) of $58.4 million decreased 0.6% from $58.7 million in the prior year. SG&A as a percent of total revenue increased 110 basis points to 28.2% from 27.1% primarily driven by lower revenue, as SG&A expenses were generally consistent year-over-year. • Interest expense, net of $26.3 million increased from $25.5 million in the prior year. • Income tax expense increased to $4.7 million from $2.2 million in the prior year. The effective tax rate increased to 28.5% from 13.0% in the prior year-to-date period, primarily due to an increase related to our investment in EWC Ventures LLC, an increase related to sta”
EWCZ European Wax Center, Inc.

European Wax Center, Inc. reported Fourth Quarter of Fiscal 2025 results: revenue $45.1 million, net income Net loss of $1.5 million.

“Results for the Fourth Quarter of Fiscal 2025 versus Fiscal 2024 • Franchisees opened 1 and closed 7 centers. We ended the quarter with 1,047 centers, representing a 1.9% decrease versus 1,067 centers in the prior year period. • System-wide sales of $225.6 million decreased 1.6% from $229.3 million in the prior year period, primarily driven by a shift in service mix. • Total revenue of $45.1 million decreased 9.3% from $49.7 million in the prior year period. • Same-store sales decreased 0.1%. • Selling, general and administrative expenses (“SG&A”) of $15.5 million increased 4.3% from $14.8 million in the prior year period. SG&A as a percent of total revenue increased 450 basis points to 34.3% from 29.8% primarily driven by strategic investments in headcount to support long-term growth initiatives and lower revenue primarily resulting from one-time support investments to franchisees. • Interest expense, net of $6.6 million increased from $6.4 million in the prior year period. • Income t”
AMPX Amprius Technologies, Inc.

Amprius Technologies, Inc. reported the full year ended December 31, 2025 results: revenue $73.0 million, net income Net loss for the year was $44.0 million, EPS Net loss per share for the year was $0.35. Guidance initiated.

“Revenue for the full year 2025 was $73.0 million, compared to $24.2 million in 2024, an increase of 202%. Net loss for the year was $44.0 million, compared to a net loss of $44.7 million in 2024. Net loss per share for the year was $0.35, compared to a loss of $0.45 per share in 2024.”
AMPX Amprius Technologies, Inc.

Amprius Technologies, Inc. reported the fourth quarter ended December 31, 2025 results: revenue $25.2 million, net income Net loss was $24.4 million, EPS Net loss per share was $0.18. Guidance initiated.

“Revenue for the fourth quarter of 2025 was $25.2 million, compared to $10.6 million in the fourth quarter of 2024. Net loss was $24.4 million, compared to a net loss of $11.4 million in the fourth quarter of 2024. Net loss per share was $0.18, compared to a net loss per share of $0.10 in the fourth quarter of 2024.”
DAIC CID Holdco, Inc.

CID Holdco, Inc. reported year ended December 31, 2025 results: revenue $5.8 million, net income $(36.7) million, EPS $(1.78) per share.

“2 ea028007701ex99-1.htm PRESS RELEASE DATED MARCH 4, 2026 Exhibit 99.1 Dot Ai Reports Fourth Quarter and Full Year 2025 Financial Results Full Year Revenue Increases to $5.8 Million Driven by Accelerating Customer Adoption; Record Q4 Revenue Validates Commercial Momentum LAS VEGAS, NV – March 4, 2026 – CID Holdco. (Nasdaq: DAIC) (“Dot Ai” or the “Company”),”
BLLN BillionToOne, Inc.

BillionToOne, Inc. updated its the year ended December 31, 2025 guidance (raised).

“On March 4, 2026 , BillionToOne, Inc. (the “Company”) issued a press release announcing financial results for the quarter and year ended December 31, 2025.”
BLLN BillionToOne, Inc.

BillionToOne, Inc. updated its the fourth quarter ended December 31, 2025 guidance (raised).

“On March 4, 2026 , BillionToOne, Inc. (the “Company”) issued a press release announcing financial results for the quarter and year ended December 31, 2025.”
MVIS MICROVISION, INC.

MICROVISION, INC. reported financial results for full year 2025.

“MicroVision Announces Fourth Quarter and Full Year 2025 Results”
MVIS MICROVISION, INC.

MICROVISION, INC. reported the fourth quarter of 2025 results: revenue $0.2 million, net income $37.8 million, EPS $0.12 per share.

“● Revenue for the fourth quarter of 2025 was $0.2 million, compared to $1.7 million for the fourth quarter of 2024. ● Net loss for the fourth quarter of 2025 was $37.8 million, or $0.12 per share, which includes $29.4 million of non-cash charges related to asset impairment and inventory write-downs partially offset by a net credit of $1.5 million of non-cash, share-based compensation expense, compared to a net loss of $31.2 million, or $0.14 per share, which includes $1.9 million of non-cash charges related to inventory write-downs and $2.0 million of non-cash, share-based compensation expense, for the fourth quarter of 2024.”
DY DYCOM INDUSTRIES INC

DYCOM INDUSTRIES INC reported fiscal year ended January 31, 2026 results: revenue $5.546 billion, net income $281.2 million, EPS $9.56 per common share diluted. Guidance initiated.

“• Contract revenues of $5.546 billion (*) increased 17.9%, or 6.5% organically • Net income of $281.2 million (*) , or $9.56* per common share diluted”
DY DYCOM INDUSTRIES INC

DYCOM INDUSTRIES INC reported fiscal 2026 fourth quarter results: revenue $1.458 billion, net income $16.3 million, EPS $0.55 per common share diluted. Guidance initiated.

“• Contract revenues of $1.458 billion (*) increased 34.4%, or 16.6% organically • Net income of $16.3 million, or $0.55 per common share diluted”
BBWI Bath & Body Works, Inc.

Bath & Body Works, Inc. reported fiscal 2026 results: EPS $3.00 and $3.25. Guidance initiated.

“For fiscal 2026, the company is forecasting net sales to decline between 4.5% to 2.5% compared to $7,291 million in fiscal 2025. Full-year 2026 earnings per diluted share is expected to be between $3.00 and $3.25 compared to $3.11 in fiscal 2025.”
BBWI Bath & Body Works, Inc.

Bath & Body Works, Inc. reported the year ended January 31, 2026 results: revenue $7,291 million, net income $649 million, EPS $3.11.

“The company reported net sales of $7,291 million for the year ended January 31, 2026, a decrease of 0.2% compared to net sales of $7,307 million for the year ended February 1, 2025. Earnings per diluted share were $3.11 for the year, compared to $3.61 in 2024. Full-year operating income was $1,126 million compared to $1,266 million last year, and net income was $649 million compared to $798 million last year.”
BBWI Bath & Body Works, Inc.

Bath & Body Works, Inc. reported the quarter ended January 31, 2026 results: revenue $2,724 million, net income $403 million, EPS $1.99.

“The company reported net sales of $2,724 million for the quarter ended January 31, 2026, a decrease of 2% compared to net sales of $2,788 million for the quarter ended February 1, 2025. Earnings per diluted share were $1.99 for the fourth quarter of 2025, compared to $2.09 last year. Fourth quarter operating income was $599 million compared to $678 million last year, and net income was $403 million compared to $453 million last year.”
ALTO Alto Ingredients, Inc.

Alto Ingredients, Inc. reported financial results for the quarter and year ended December 31, 2025.

“On March 4, 2026, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and twelve months ended December 31, 2025.”
NC NACCO INDUSTRIES INC

NACCO INDUSTRIES INC reported the year ended December 31, 2025 results: net income $17.6 million, EPS $2.35/share.

“FY Highlights: • Net income of $17.6 million, or $2.35/share, versus $33.7 million, or $4.55/share, in 2024 • Adjusted EBITDA of $48.9 million compared with $59.4 million in 2024 ◦ 2024 included $13.6 million of business interruption insurance recoveries”
NC NACCO INDUSTRIES INC

NACCO INDUSTRIES INC reported the three months ended December 31, 2025 results: revenue $66,778, net income $(3,840), EPS $(0.52).

“Three Months Ended ($ in thousands except per share amounts) 12/31/25 12/31/24 Year/Year $ Change 9/30/25 Sequential $ Change Revenues $66,778 $70,418 $(3,640) $76,614 $(9,836) Gross profit $12,028 $8,476 $3,552 $9,971 $2,057 Operating profit $7,573 $3,883 $3,690 $6,777 $796 Net income (loss) $(3,840) $7,564 $(11,404) $13,254 $(17,094) Diluted EPS $(0.52) $1.02 $(1.54) $1.78 $(2.30)”
PLPC PREFORMED LINE PRODUCTS CO

PREFORMED LINE PRODUCTS CO reported the year ended December 31, 2025 results: revenue $669.3 million, net income $35.3 million, EPS $7.14 per diluted share.

“Net sales increased 13% to $669.3 million for the full year 2025 compared to $593.7 million in 2024.”
PLPC PREFORMED LINE PRODUCTS CO

PREFORMED LINE PRODUCTS CO reported the quarter ended December 31, 2025 results: revenue $173.1 million, net income $8.4 million, EPS $1.72 per diluted share.

“Net sales in the fourth quarter of 2025 were $173.1 million compared to $167.1 million in the fourth quarter of 2024, a 4% increase.”
NPK NATIONAL PRESTO INDUSTRIES INC

NATIONAL PRESTO INDUSTRIES INC reported the year ended December 31, 2025 results: revenue $503,524,000, net income $33,084,000, EPS $4.63.

“of common shares outstanding for the respective periods. In response to questions about the Company’s sales, Maryjo Cohen, President, stated, “Net 2025 consolidated sales were $503.5 million, a 29.7% increase from 2024’s levels. Net earnings were down $‐‐‐8.4 million or 20.2% to $33.1 million ($4.63 per share) from 2024’s $41.5 million ($5.82 per share). The revenue”
RJET REPUBLIC AIRWAYS HOLDINGS INC.

REPUBLIC AIRWAYS HOLDINGS INC. reported the fourth quarter and full year 2025 results: revenue $1.7 billion, net income $76.2 million, or $1.87 per diluted share.

“of $1.2 billion Full year highlights: • Net income of $76.2 million, or $1.87 per diluted share • Pre-tax income of $113.4 million and EBITDAR 1 of $295.3 million • Revenues of $1.7 billion on increased block hour activity, up 18.2% • On an adjusted basis 1 , excluding executive separation and merger-related costs, net income was $114.0 million or $2.80 per diluted”
ICCC IMMUCELL CORP /DE/

IMMUCELL CORP /DE/ reported financial results for year ended December 31, 2025.

“On March 4, 2026 ImmuCell Corporation (the "Company") issued a press release announcing its unaudited financial results for the quarter and year ended December 31, 2025.”
CPSH CPS TECHNOLOGIES CORP/DE/

CPS TECHNOLOGIES CORP/DE/ reported financial results for the fiscal fourth quarter ended December 27, 2025.

“On March 2, 2026, the Company issued a press release announcing its financial results for the three months ended December 27, 2025. A copy of the press release is attached hereto as Exhibit 99 and is incorporated herein in its entirety by reference.”
DAKT DAKTRONICS INC /SD/

DAKTRONICS INC /SD/ reported its fiscal 2026 third quarter which ended January 31, 2026 results: revenue $181.9 million.

“today reported results for its fiscal 2026 third quarter which ended January 31, 2026. Fiscal Q3 2026 financial highlights include: • Sales of $181.9 million”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.